Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Kirchmaier

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Der Internist|August 21, 2010
[Congenital thrombocytopathies]C M Kirchmaier, D Pillitteri
Wiener Klinische Wochenschrift|December 21, 1984
Substitution of antithrombin IIIH K Breddin, C M Kirchmaier
Der Radiologe|August 1, 1981
[Nonocclusive mesenteric ischemia (author's transl)]E Trüber, C M Kirchmaier, D Wurbs
European Journal of Clinical Pharmacology|January 1, 1995
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)P Thürmann, S Harder, C M Kirchmaier
Der Internist|November 20, 2009
[Bleeding complications due to anticoagulatoric therapy]R Mahnel, S Bassus, C M Kirchmaier
Advances in Experimental Medicine and Biology|January 1, 1984
On the mechanism of platelet activation during hemostasis and thrombosis and on the effects of platelet inhibiting drugsK Breddin, N Bender, C M Kirchmaier
Thrombosis Research|July 1, 1989
Changes of spontaneous and induced platelet aggregation in the presence of a human endothelial cell monolayerI Altorjay, C M Kirchmaier, H K Breddin
Platelets|March 15, 2005
Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIaW Wegert, S Harder, S Bassus, et al.
Haemostasis|May 1, 1997
Analysis of glycoprotein Ia, Ib, IIb and IV RNA in platelets: quantitative determination using fluorescence-based polymerase chain reactionC Seidl, J Siehl, C M Kirchmaier, et al.
VASA. Supplementum|January 1, 1991
[Objective assessment of the risk of edema in patients with venous diseases and healthy vein probands using optoelectronic volumetry]O K Bellinger, C M Kirchmaier, H K Breddin
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Der Internist|August 21, 2010
[Congenital thrombocytopathies]C M Kirchmaier, D Pillitteri
Wiener Klinische Wochenschrift|December 21, 1984
Substitution of antithrombin IIIH K Breddin, C M Kirchmaier
Der Radiologe|August 1, 1981
[Nonocclusive mesenteric ischemia (author's transl)]E Trüber, C M Kirchmaier, D Wurbs
European Journal of Clinical Pharmacology|January 1, 1995
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)P Thürmann, S Harder, C M Kirchmaier
Der Internist|November 20, 2009
[Bleeding complications due to anticoagulatoric therapy]R Mahnel, S Bassus, C M Kirchmaier
Advances in Experimental Medicine and Biology|January 1, 1984
On the mechanism of platelet activation during hemostasis and thrombosis and on the effects of platelet inhibiting drugsK Breddin, N Bender, C M Kirchmaier
Thrombosis Research|July 1, 1989
Changes of spontaneous and induced platelet aggregation in the presence of a human endothelial cell monolayerI Altorjay, C M Kirchmaier, H K Breddin
Platelets|March 15, 2005
Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIaW Wegert, S Harder, S Bassus, et al.
Haemostasis|May 1, 1997
Analysis of glycoprotein Ia, Ib, IIb and IV RNA in platelets: quantitative determination using fluorescence-based polymerase chain reactionC Seidl, J Siehl, C M Kirchmaier, et al.
VASA. Supplementum|January 1, 1991
[Objective assessment of the risk of edema in patients with venous diseases and healthy vein probands using optoelectronic volumetry]O K Bellinger, C M Kirchmaier, H K Breddin
Pageof 5